Citius Oncology, Inc. CTOR Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s total current liabilities?
- Citius Oncology, Inc. (CTOR) reported total current liabilities of $58.81M in Q1 2026.
- How has Citius Oncology, Inc.'s total current liabilities changed year-over-year?
- Citius Oncology, Inc.'s total current liabilities increased by 18.2% year-over-year, from $49.74M to $58.81M.
- What is the long-term trend for Citius Oncology, Inc.'s total current liabilities?
- Over 3 years (2022 to 2025), Citius Oncology, Inc.'s total current liabilities has grown at a 470.3% compound annual growth rate (CAGR), from $266.86K to $49.49M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.